We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$175M
AUM Growth
–
Cap. Flow
+$165M
Cap. Flow %
94.32%
Top 10 Hldgs %
41.58%
Holding
70
New
68
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$11.4M
2
MRK icon
Merck
MRK
+$8.38M
3
BIIB icon
Biogen
BIIB
+$7.76M
4
ZBH icon
Zimmer Biomet
ZBH
+$7.13M
5
GILD icon
Gilead Sciences
GILD
+$5.92M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 61.37%
2 Industrials 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
1
Amgen
AMGN
$210B
$11.4M 6.5%
+100,000
New +$11.4M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$8.99M 5.12%
+50,000
New +$8.85M
MRK icon
3
Merck
MRK
$317B
$8.76M 4.99%
+183,400
New +$8.38M
BIIB icon
4
Biogen
BIIB
$30.9B
$8.39M 4.78%
+30,000
New +$7.76M
ZBH icon
5
Zimmer Biomet
ZBH
$18.6B
$7.46M 4.25%
+82,400
New +$7.13M
GILD icon
6
Gilead Sciences
GILD
$167B
$6.38M 3.64%
+85,000
New +$5.92M
MRK icon
7
CALL
Merck
MRK
$317B
$6.16M 3.51%
+131,000
New +$5.99M
IWM icon
8
PUT
iShares Russell 2000 ETF
IWM
$83.1B
$5.58M 3.18%
+50,000
New +$5.52M
VTRS icon
9
Viatris
VTRS
$20.6B
$4.99M 2.84%
+115,000
New +$4.73M
CLDX icon
10
Celldex Therapeutics
CLDX
$3.07B
$4.84M 2.76%
+13,333
New +$5.14M
CI icon
11
Cigna
CI
$72B
$4.37M 2.49%
+50,000
New +$4.09M
TRNX
12
CALL
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$4.36M 2.49%
+250,000
New +$4.71M
AMGN icon
13
CALL
Amgen
AMGN
$210B
$3.96M 2.26%
+35,000
New +$3.98M
LGND icon
14
Ligand Pharmaceuticals
LGND
$6.02B
$3.94M 2.25%
+120,225
New +$3.92M
INCY icon
15
Incyte
INCY
$24.4B
$3.8M 2.16%
+75,000
New +$3.26M
ARTC
16
CALL
DELISTED
ARTHROCARE CORP
ARTC
$3.76M 2.14%
+100,000
New +$3.7M
TRNX
17
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$3.76M 2.14%
+200,000
New +$3.77M
COV
18
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$3.4M 1.94%
+50,000
New +$3.25M
ALKS icon
19
Alkermes
ALKS
$8.32B
$3.05M 1.74%
+75,000
New +$2.77M
ARTC
20
DELISTED
ARTHROCARE CORP
ARTC
$3.02M 1.72%
+75,000
New +$2.78M
FRX
21
CALL
DELISTED
FOREST LABORATORIES INC
FRX
$2.81M 1.6%
+50,000
New +$2.52M
ELGX
22
DELISTED
Endologix Inc
ELGX
$2.79M 1.59%
+16,000
New +$2.75M
LSTA icon
23
Lisata Therapeutics
LSTA
$10.8M
$2.73M 1.55%
+2,667
New +$2.64M
PBYI icon
24
Puma Biotechnology
PBYI
$398M
$2.59M 1.48%
+25,000
New +$1.47M
ETRM
25
DELISTED
EnteroMedics Inc.
ETRM
$2.29M 1.31%
+1,071
New +$1.73M
1
2 3

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Iguana Healthcare Management, which disclosed 70 positions worth $175M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Amgen: 100,000 shares worth $11.4M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, followed by Industrials.

  • Iguana Healthcare Management's largest Q4 2013 buy was Amgen: 100,000 shares worth $11.4M.
  • Iguana Healthcare Management's ten largest holdings make up 42% of its $175M portfolio in Q4 2013.
  • Iguana Healthcare Management disclosed 70 positions in Q4 2013, its first 13F filing on record.

Based on Iguana Healthcare Management's 13F filing for Q4 2013, filed 14 Feb 2014.